S&P 500 Rises 1.54% This Week to 5303.27 — Data Talk
The S&P 500 Index is up 80.59 points or 1.54% this week to 5303.27
--Up for four consecutive weeks
--Up 336.04 points or 6.77% over the last four weeks
--Largest four-week point and percentage gain since the week ending Nov. 24, 2023
--Longest winning streak since the week ending Feb. 9, 2024, when the market rose for five straight weeks
--Today it is up 6.17 points or 0.12%
--Second highest close in history
--Up nine of the past 12 trading days
--Off 0.09% from its record close of 5308.15 hit Wednesday, May 15, 2024
--Up 57.41% from the Election Day close of 3369.16 on Tuesday, Nov. 3, 2020
--Up 37.68% from the Inauguration Day close of 3851.85 on Wednesday, Jan. 20, 2021
--Today's closing value is the second highest this year
--Off 0.09% from its 52-week high of 5308.15 hit Wednesday, May 15, 2024
--Up 28.87% from its 52-week low of 4115.24 hit Wednesday, May 24, 2023
--Rose 26.51% from 52 weeks ago
--Off 0.09% from its 2024 closing high of 5308.15 hit Wednesday, May 15, 2024
--Up 13.11% from its 2024 closing low of 4688.68 hit Thursday, Jan. 4, 2024
--Month-to-date it is up 5.31%
--Year-to-date it is up 533.44 points or 11.18%
Data based on preliminary market closing values
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 17, 2024 16:29 ET (20:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks